432 related articles for article (PubMed ID: 15452194)
1. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Muià C; Patel NS; Threadgill MD; Bramanti P; De Sarro A; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 Feb; 312(2):449-57. PubMed ID: 15452194
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of poly(ADP-ribose) polymerase modulate signal transduction pathways and the development of bleomycin-induced lung injury.
Genovese T; Mazzon E; Di Paola R; Muià C; Threadgill MD; Caputi AP; Thiemermann C; Cuzzocrea S
J Pharmacol Exp Ther; 2005 May; 313(2):529-38. PubMed ID: 15644425
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of FeTSPP, a peroxynitrite decomposition catalyst, in a mouse model of spinal cord injury.
Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Bramanti P; Cuzzocrea S
Free Radic Biol Med; 2007 Sep; 43(5):763-80. PubMed ID: 17664140
[TBL] [Abstract][Full Text] [Related]
4. Effects of a metalloporphyrinic peroxynitrite decomposition catalyst, ww-85, in a mouse model of spinal cord injury.
Genovese T; Mazzon E; Esposito E; Di Paola R; Murthy K; Neville L; Bramanti P; Cuzzocrea S
Free Radic Res; 2009 Jul; 43(7):631-45. PubMed ID: 19418318
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of tyrosine kinase-mediated cellular signalling by Tyrphostins AG126 and AG556 modulates secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
Neuropharmacology; 2007 Jun; 52(7):1454-71. PubMed ID: 17418876
[TBL] [Abstract][Full Text] [Related]
6. Glycyrrhizin reduces secondary inflammatory process after spinal cord compression injury in mice.
Genovese T; Menegazzi M; Mazzon E; Crisafulli C; Di Paola R; Dal Bosco M; Zou Z; Suzuki H; Cuzzocrea S
Shock; 2009 Apr; 31(4):367-75. PubMed ID: 18665052
[TBL] [Abstract][Full Text] [Related]
7. Evidence for the role of mitogen-activated protein kinase signaling pathways in the development of spinal cord injury.
Genovese T; Esposito E; Mazzon E; Muià C; Di Paola R; Meli R; Bramanti P; Cuzzocrea S
J Pharmacol Exp Ther; 2008 Apr; 325(1):100-14. PubMed ID: 18180375
[TBL] [Abstract][Full Text] [Related]
8. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Crisafulli C; Esposito E; Di Paola R; Muià C; Di Bella P; Meli R; Bramanti P; Cuzzocrea S
Neuroscience; 2007 Nov; 150(1):168-81. PubMed ID: 17945432
[TBL] [Abstract][Full Text] [Related]
9. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Min W; Di Paola R; Muià C; Li JH; Esposito E; Bramanti P; Xu W; Massuda E; Zhang J; Wang ZQ
J Pharmacol Exp Ther; 2006 Oct; 319(1):127-38. PubMed ID: 16825529
[TBL] [Abstract][Full Text] [Related]
10. Effect of 17beta-estradiol on signal transduction pathways and secondary damage in experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Esposito E; Di Paola R; Muià C; Crisafulli C; Peli A; Bramanti P; Chaudry IH
Shock; 2008 Mar; 29(3):362-71. PubMed ID: 17704735
[TBL] [Abstract][Full Text] [Related]
11. N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone reduces severity of experimental spinal cord injury.
Genovese T; Mazzon E; Esposito E; Muià C; Di Paola R; Crisafulli C; Bramanti P; Cuzzocrea S
Shock; 2007 Mar; 27(3):258-65. PubMed ID: 17304106
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory effects of etanercept in an experimental model of spinal cord injury.
Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Bramanti P; Cuzzocrea S
J Pharmacol Exp Ther; 2006 Mar; 316(3):1006-16. PubMed ID: 16303916
[TBL] [Abstract][Full Text] [Related]
13. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
14. Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin.
Genovese T; Mazzon E; Muià C; Bramanti P; De Sarro A; Cuzzocrea S
J Pineal Res; 2005 Apr; 38(3):198-208. PubMed ID: 15725342
[TBL] [Abstract][Full Text] [Related]
15. Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein.
Mazzon E; Genovese T; Di Paola R; Muià C; Crisafulli C; Malleo G; Esposito E; Meli R; Sessa E; Cuzzocrea S
Eur J Pharmacol; 2006 Nov; 549(1-3):149-56. PubMed ID: 16979620
[TBL] [Abstract][Full Text] [Related]
16. Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator.
Paterniti I; Mazzon E; Emanuela E; Paola RD; Galuppo M; Bramanti P; Cuzzocrea S
Free Radic Res; 2010 Jun; 44(6):694-709. PubMed ID: 20370565
[TBL] [Abstract][Full Text] [Related]
17. Absence of endogenous interleukin-10 enhances secondary inflammatory process after spinal cord compression injury in mice.
Genovese T; Esposito E; Mazzon E; Di Paola R; Caminiti R; Bramanti P; Cappelani A; Cuzzocrea S
J Neurochem; 2009 Mar; 108(6):1360-72. PubMed ID: 19183262
[TBL] [Abstract][Full Text] [Related]
18. TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome.
Genovese T; Mazzon E; Crisafulli C; Di Paola R; Muià C; Esposito E; Bramanti P; Cuzzocrea S
Shock; 2008 Jan; 29(1):32-41. PubMed ID: 17621255
[TBL] [Abstract][Full Text] [Related]
19. Effect of Apocynin, an inhibitor of NADPH oxidase, in the inflammatory process induced by an experimental model of spinal cord injury.
Impellizzeri D; Mazzon E; Esposito E; Paterniti I; Bramanti P; Cuzzocrea S
Free Radic Res; 2011 Feb; 45(2):221-36. PubMed ID: 20954833
[TBL] [Abstract][Full Text] [Related]
20. Role of endogenous ligands for the peroxisome proliferators activated receptors alpha in the secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Di Paola R; Cannavò G; Muià C; Bramanti P; Cuzzocrea S
Exp Neurol; 2005 Jul; 194(1):267-78. PubMed ID: 15899263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
